GENERIC NAME OF THE MEDICINAL PRODUCT:

Levofloxacin Intravenous Infusion BP (0.5% W/V or 500mg/100ml)

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A. Levofloxacin Intravenous Infusion BP (0.5% W/V or 500mg/100ml)
Composition:
Each 100 ml contains:
Levofloxacin Hemihydrate
Eq. to Levofloxacin USP………………...….0.5gm
Dextrose Anhydrous USP……………5%w/v
Water for Injection BP……………..….....q.s

No preservative added.
For ingredient, dosage & precaution refer to leaflet.

THERAPEUTIC INDICATIONS:

Levofloxacin injection is used to treat bacterial infections in many different parts of the body. It is also used to prevent an anthrax infection after inhalational exposure. This medicine is also used to treat and prevent plague (including pneumonic and septicemic plague)

DIRECTION OF USE:

To be used with Non-pyrogenic LV. administration set with aseptic technique.
For I.V Use Only

CAUTION & WARNING:

CAUTION: Even Invisible damage to bottle during transit, Storage or handling may result in contamination. Do not use if contamination is found leaking on squeezing, contents not clear or contains visible solid particles.
TO BE SOLD BYTHE RETAILERS ON THE PRESCRIPTION OF A REGISTERED MEDICAL PRACTITIONER ONLY.
Warning:
Metronidazole has been. shown to be carcinogenic in mice & rats. Unnecessary use of the drug should therefore be avoided.

STORAGE & DOSAGE:

Storage: Keep in cool place Store below 25°C. Protect from light. Do not freeze.
Keep all medicines out of reach of children.
FOR HUMAN USE ONLY
Read enclosed leaflet before use

Dosage: As directed by Physician

Levofloxacin Intravenous Infusion BP Technical Specifications:

Product Name:Levofloxacin Intravenous Infusion BP
Brand Name:Levoxtaj
Strength:(0.5% W/V or 500mg/100ml)
Packing:100mL IV Bottle
Pack Insert/Leaflet:PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics)
Regulatory Documents:COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier
Therapeutic use:Anti-bacterial & Quinolone Anti-biotics
Indication: Treat bacterial infections
Prevent an anthrax infection after inhalational exposureTreat and prevent plague (including pneumonic and septicaemic plague)
Storage:Keep in a cool place, temperature not exceeding 25°C. Do not freeze or refrigerate.

Levofloxacin Intravenous Infusion BP Manufacturers & Exporters in India & Overseas

Taj Pharmaceutical is a prominent Levofloxacin Intravenous Infusion BP manufacturer in India and is known to provide the best quality medicine that is safe to use. Being one of the authorized and trusted GMP and WHO certified companies, we strictly follow the set guidelines of the regulatory body. This ensures that the product we manufacture and export meets the required norms of the Pharmaceutical industry.

The company has got many years of experience in manufacturing, supplying and exporting Levofloxacin Intravenous Infusion. The medicine is used for treating infections that are caused by bacteria in various parts of the body. Besides, it is also used for preventing infection of anthrax after the inhalational exposure.

Why Levofloxacin Intravenous Infusion BP is Prescribed?

Fluoroquinolones are a class of antibiotics that includes levofloxacin injectable. It functions by eradicating the infection-causing germs. Colds, the flu, or other viral diseases cannot be treated with antibiotics like levofloxacin injection. Antibiotic overuse raises the likelihood that you’ll get an infection later on that is resistant to antibiotic therapy.

How Should Levofloxacin Intravenous Infusion BP Be Used?

Levofloxacin injection is administered as a solution (liquid) using a vein-accessing needle or catheter. It is often intravenously (into a vein) infused (slowly administered) once per 24 hours over a period of 60 or 90 minutes. The sort of infection you have will determine how long your therapy will last. The duration is recommended by your doctor.

Levofloxacin injections are available both in hospitals and for use at home. Your doctor will show how to inject the drug to you if you will be administering levofloxacin injection at home. If you have any issues, consult your healthcare professional. If you experience any difficulties administering levofloxacin injection, see your healthcare practitioner for advice. During the first few days of your levofloxacin injection treatment, you will start feeling better. Call your doctor if your symptoms do not disappear or worsen.

Side Effects

Being an eminent Levofloxacin Intravenous Infusion BP manufacturer and exporter, we also export the product across the globe. However, some consumer might experience side effects such as:

  • Headache
  • Nausea
  • Lightheadedness
  • Diarrhea
  • Trouble sleeping
  • Dizziness
  • Redness/Pain/swelling at the injection site

Precautions

Check out some of the precautionary measures that you must know about the medicine:

  • People who are allergic to or have had a severe reaction to fluoroquinolone drugs are given levofloxacin as an injectable. If you have any concerns about an adverse reaction or have had a negative experience with a different kind of medication, let your doctor and know.
  • Inform your doctor if you have a prolonged QT interval or if anybody in your family has ever experienced it, as well as if your blood potassium or magnesium levels are low.
  • Inform your physician if you are nursing a baby, intend to get pregnant, or are already pregnant. Call your doctor if you become pregnant while taking levofloxacin injectable.
  • Until you are aware of how this drug affects you, refrain from operating machinery, driving a car, or engaging in other tasks that call for attentiveness or coordination.
  • Your skin may become more susceptible to ultraviolet or sunlight after receiving a levofloxacin injection. Avoid excessive or extended exposure to the sun and call your doctor if your skin becomes red, puffy, or blistered, as would occur with severe sunburn.

GENERIC NAME OF THE MEDICINAL PRODUCT:

  • Levofloxacin Intravenous Infusion BP (0.5% W/V or 500mg/100ml)

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  1. Levofloxacin Intravenous Infusion BP (0.5% W/V or 500mg/100ml)
    Composition:
    Each 100 ml contains:
    Levofloxacin Hemihydrate
    Eq. to Levofloxacin   …….…………….0.5gm
    Dextrose Anhydrous USP……………5%w/v
    Water for Injection BP……………..……..q.sNo preservative added.For ingredient, dosage & precaution refer to leaflet.

THERAPEUTIC INDICATIONS:

Levofloxacin injection is used to treat bacterial infections in many different parts of the body. It is also used to prevent an anthrax infection after inhalational exposure. This medicine is also used to treat and prevent plague (including pneumonic and septicemic plague).

DIRECTION OF USE:

  • To be used with Non-pyrogenic LV. administration set with aseptic technique.
  • For I.V Use Only

 CAUTION & SCHEDULE:

CAUTION: Even Invisible damage to bottle during transit, Storage or handling may result in contamination. Do not use if contamination is found leaking on squeezing, contents not clear or contains visible solid particles.

To be sold by the retailers on the prescription of a registered medical practitioner only.

Warning:

Metronidazole has been. shown to be carcinogenic in mice & rats. Unnecessary use of the drug should therefore be avoided.

 STORAGE & DOSAGE:

Storage: Keep in cool place Store below 25°C. Protect from light. Do not freeze.

Keep all medicines out of reach of children.

FOR HUMAN USE ONLY

Read enclosed leaflet before use

Dosage: As directed by Physician

Levofloxacin Intravenous Infusion BP I.V. Regulatory Documents:

  • Certificate of Analysis (COA)
  • Certificate of Pharmaceuticals Product (COPP)
  • Free Sale Certificate (FSC)
  • Method of Analysis (MOA)
  • CTD Dossier / ACTD Dossiers / eCTD Dossiers
  • Stability Data (Accelerated stability / Long term stability / Zone 4b)

Levofloxacin Intravenous Infusion BP I.V Export Market

Taj Pharmaceutical is top manufacturer and suppliers of best quality Levofloxacin Intravenous Infusion. It is known to export medicines in following listed geographical location:

Southeast Asia: Indonesia Brunei Darussalam, Cambodia, Singapore, Laos, Malaysia, Myanmar, Philippines, Thailand,Vietnam

Russia and CIS Countries: Kyrgyzstan, Georgia, Turkmenistan, Tajikistan, Armenia, Uzbekistan, Kazakhstan, Ukraine, Azerbaijan, Moldova, Russia, and Belarus

GCC/ Middle East Countries: UAE, Bahrain, Lebanon, Saudi Arabia, Oman, Iraq, Jordan, Yemen

African Countries: Benin, Nigeria, Tanzania, Zambia, Liberia, Sudan, Angola

Other Asian Countries: Sri Lanka, Mauritius, Malaysia, Myanmar, Cambodia, Bhutan, Nepal

Manufacturing Standard Operating Procedure:

Other Large Volume Parenterals (LVPs):

Other Dry Powder Injections:

Other Liquid Injections: